ABSTRACT

Nanotechnology integration has led in significant improvements in ocular medicine administration. Even though numerous standard dose forms are employed, shorter bioavailability and retention durati on continue to be a serious concern in the ocular drug delivery system..In addition, a number of other barriers exist that affect. The drug's solubility and permeability are reduced as a result of It has a short er residence duration on the ocular surface..The application of nanotechnology could be the most effe ctive solution to these issues..The field of all nanocarriers has showed considerable potential in offerin g precise medicine delivery.to the ocular tissues. Compact size, biocompatibility, and surface modification improve medication solubility, lengthen release, and increase bioavailability..Nanotechnology also makes it easier to implant medicinal molec ules to treat a number of eye.conditions such as infections, macular degeneration, and glaucoma./The goal of these improvements is to remove barriers and issues in the ocular medication delivery.system. This review emphasises how nanotechnology can change the delivery of ophthalmic drugs, potentially leading to more effective and patient friendly therapies for eye illnesses. Keywords: Nanotechnology, Nanocarriers, Ocular drug delivery, Glaucoma
Publication date: 01/03/2026

https://ijbpas.com/pdf/2026/March/MS_IJBPAS_2026_9969.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2026/15.3.9969